Seelos Therapeutics, Inc. Operating Lease Right-of-Use Assets
Seelos Therapeutics, Inc. had Operating Lease Right-of-Use Assets of $47.00 thousand as of 2024-06-30, per its 10-Q filed 2024-08-14.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2024-08-14
- 2024-06-30: Operating Lease, Right-of-Use Asset $47.00K.
- 2024-03-31: Operating Lease, Right-of-Use Asset $62.00K.
- 2023-12-31: Operating Lease, Right-of-Use Asset $15.00K.
- 2023-09-30: Operating Lease, Right-of-Use Asset $30.00K.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2024-06-30 | $47.00K 10-Q · filed 2024-08-14 |
| 2024-03-31 | $62.00K 10-Q · filed 2024-05-14 |
| 2023-12-31 | $15.00K 10-Q · filed 2024-08-14 |
| 2023-09-30 | $30.00K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $44.00K 10-Q · filed 2023-08-11 |
| 2023-03-31 | $58.00K 10-Q · filed 2023-05-12 |
| 2022-12-31 | $72.00K 10-K · filed 2024-03-06 |
| 2022-06-30 | $13.00K 10-Q · filed 2022-08-05 |
| 2022-03-31 | $26.00K 10-Q · filed 2022-05-10 |
| 2021-12-31 | $39.00K 10-K · filed 2023-03-10 |
| 2021-09-30 | $51.00K 10-Q · filed 2021-11-05 |
| 2021-06-30 | $63.00K 10-Q · filed 2021-08-06 |
| 2021-03-31 | $74.00K 10-K · filed 2022-03-04 |
| 2020-12-31 | $0.00 10-Q · filed 2021-04-30 |